CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 113 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q2 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,198 | -37.5% | 2,895 | -9.0% | 0.04% | -36.7% |
| Q2 2023 | $101,156 | +10.3% | 3,182 | -15.4% | 0.06% | +20.0% |
| Q1 2023 | $91,706 | -44.2% | 3,760 | -27.8% | 0.05% | -41.9% |
| Q4 2022 | $164,355 | +35.8% | 5,211 | +21.3% | 0.09% | +79.2% |
| Q3 2022 | $121,000 | +7.1% | 4,295 | +0.8% | 0.05% | +14.3% |
| Q2 2022 | $113,000 | -38.3% | 4,259 | -18.3% | 0.04% | -48.8% |
| Q1 2022 | $183,000 | +2.2% | 5,216 | -5.6% | 0.08% | +20.6% |
| Q4 2021 | $179,000 | -61.3% | 5,525 | -64.7% | 0.07% | -66.5% |
| Q3 2021 | $462,000 | +9.5% | 15,667 | -5.0% | 0.20% | +16.7% |
| Q2 2021 | $422,000 | – | 16,484 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 60,632,356 | $1,965,701,000 | 23.51% |
| Affinity Asset Advisors, LLC | 225,000 | $7,295,000 | 2.65% |
| Perceptive Advisors | 10,173,454 | $329,822,000 | 2.54% |
| Artal Group S.A. | 1,500,000 | $48,630,000 | 1.32% |
| Rock Springs Capital Management LP | 1,648,435 | $53,442,000 | 1.24% |
| RTW INVESTMENTS, LP | 666,666 | $21,613,000 | 0.32% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 8,900 | $289,000 | 0.28% |
| EAM Investors, LLC | 39,907 | $1,294,000 | 0.21% |
| FEDERATED HERMES, INC. | 3,113,333 | $100,934,000 | 0.19% |
| Alkeon Capital Management | 1,909,035 | $61,891,000 | 0.12% |